Euroscicon, Cineworld: The O2, Peninsula Square, London, UK
02 October 2013
Pseudotype viruses are rapidly establishing themselves as important research and diagnostic tools of basic and clinical scientists facilitating the detailed study of individual viral genes, host cell receptors and highly pathogenic viruses, circumventing the need for high-level biosafety containment. The switching of surface envelope proteins expressed on the surface of these pseudotypes enables them to be used as surrogate viruses in neutralization/antiviral screening assays and for the study of cell–virus receptor interactions. This meeting encompasses the many diverse applications of pseudotype technologies from a practical, translational and public health perspective.
|
|
Invited Speakers:
|
|
Dr Nigel James Temperton, Medway School of Pharmacy, The Universities of Greenwich and Kent, Kent Dr Janet Daly, Nottingham University, UK Dr Simon Scott, Medway School of Pharmacy, University of Kent, UK Dr Edward Wright, Westminster University, UK Dr David Griffiths, Moredun Research Institute, Pentlands Science Park, UK Professor Brian Willett, University of Glasgow Scotland Katherine Sutherland, Microbiology Services, Colindale Public Health England Dr Alex Tarr, Queen's Medical Centre
|
|